Overview
Intestinal epithelial dysplasia refers to abnormal cell growth in the lining of the intestines, often indicative of precancerous changes that may progress to malignancy if left untreated. 1 focuses on dysplasia grading in oral epithelial dysplasia, highlighting challenges in consistent diagnosis which may parallel issues in intestinal contexts.Diagnosis
Histopathologic Examination: Essential for diagnosing dysplasia, typically involving biopsy samples.
Grading Systems: Utilize standardized grading systems (e.g., degree of dysplasia) for consistency. 1 demonstrates the importance of consensus among pathologists in grading accuracy.
Interobserver Agreement: Achieving consensus through multiple pathologist reviews and adjudication processes improves diagnostic reliability. 1Management
Surgical Resection: Primary treatment for high-grade dysplasia or when dysplasia is suspected to be progressing towards malignancy.
Endoscopic Surveillance: Regular monitoring for low-grade dysplasia to detect early progression.
Chemoprevention: Use of agents like nonsteroidal anti-inflammatory drugs (NSAIDs) may be considered in some guidelines, though specific dosing is not detailed in provided abstracts.Special Populations
Pregnancy: Specific management strategies for dysplasia in pregnant patients are not addressed in the provided abstracts.
Pediatrics: Management approaches tailored for pediatric patients are not covered in the given sources.
Elderly: Considerations for elderly patients, including comorbidities and treatment tolerance, are not detailed in the abstracts.
Comorbidities: Impact of comorbidities on dysplasia management is not discussed in the provided abstracts.Key Recommendations
Implement a multi-pathologist review process with adjudication for accurate dysplasia grading to enhance diagnostic consistency. (Evidence: Moderate 1)
Regular endoscopic surveillance should be considered for patients with low-grade dysplasia to monitor for progression. (Evidence: Expert opinion)
Surgical intervention is recommended for high-grade dysplasia or cases with high risk of malignancy progression. (Evidence: Expert opinion)References
1 Speight PM, Abram TJ, Floriano PN, James R, Vick J, Thornhill MH et al.. Interobserver agreement in dysplasia grading: toward an enhanced gold standard for clinical pathology trials. Oral surgery, oral medicine, oral pathology and oral radiology 2015. link